Prevalence of Depression and Anxiety Among Breast Cancer Patients

  • days left to enroll
  • participants needed
  • sponsor
    Kazakh Medical University of Continuing Education
Updated on 28 August 2021
depressed mood


Depression and anxiety in patients with breast cancer is serious comorbidity that affects the quality of life for patients, and their survival rates as they have poorer health outcomes. Furthermore, patients' high psychological burden is linked to higher healthcare costs. The investigation of the depression and anxiety symptoms prevalence among newly diagnosed breast cancer patients will help to navigate the health policy adjustment and psycho-social support system requirements. This study aims to investigate the prevalence of depression and anxiety symptoms among newly diagnosed breast cancer patients in Almaty, Kazakhstan, and associated risk factors.

Condition Endogenous depression, Depression, Breast Cancer, ANXIETY NEUROSIS, Anxiety, Breast Cancer Diagnosis, Depressed, Anxiety Symptoms, Anxiety Disorders, breast carcinoma, depressive disorder, cancer, breast, anxiety disorder, depressed mood, miserable, depressive disorders, anxious
Clinical Study IdentifierNCT05011409
SponsorKazakh Medical University of Continuing Education
Last Modified on28 August 2021


Yes No Not Sure

Inclusion Criteria

Female adults with confirmed diagnosis of breast cancer within the 6 months study enrollment
TNM stage I-IV
Russian or Kazakh language proficiency
Ability to provide informed consent

Exclusion Criteria

Current psychotic disorder, manic episode, serious neurological disorder, intellectual disability, or developmental disorder
Current active suicidal ideation
Referral to palliative care
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note